2026031220 — GYC/GGpeps Retatrutide
Independently TestedGYC/GGpeps | Retatrutide, last activity 2 months ago
A community group test of this batch has finished. The vendor does not publish certificates for its batches; this one has none. First seen last month, it has generated no community reports.
14 related batch concerns · summary from 4 sources · updated Aug 15
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
Related batches
5 of 5 tested
same lot series
This batch has endotoxin at 57.403 EU/vial per the vendor's Janoshik certificate—over five times the 10 EU/vial working…
same lot series
One quality concern has been raised, though three positive reports are also on file
Tirzepatide, same vendor
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
same lot series
An independent lab test returned 99.01% purity with 16.65 mg measured fill, in line with this vendor's other…
Community Intelligence
- 2 concern reports involving 2026041210
- 1 concern report involving 2026091215
- 1 concern report involving 2026061215
- 2 concern reports involving 2026071210
- 1 concern report involving 2026071220
- 1 concern report involving 2026031230
- 1 concern report involving 2026061030
- 1 concern report involving 2026031310
- 1 concern report involving 2026056500
- 1 concern report involving 2026072850
- 1 concern report involving REPTN
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other GYC/GGpeps Retatrutide batches, not this one.
Also known as: R2020260312202R20-2026031220-2R202026031220R20-2026031220
Activity
No community activity tracked yet.
Vendor
GYC/GGpeps